Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV

Since the advent of tyrosine kinase inhibitors, the impact of age on outcome of chronic myeloid leukemia (CML) patients has changed. We therefore analyzed patients from the randomized CML study IV to investigate disease manifestations and outcome in different age groups. One thousand five hundred tw...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalmanti, Lida, Saussele, Susanne, Lauseker, Michael, Proetel, Ulrike, Müller, Martin C., Hanfstein, Benjamin, Schreiber, Annette, Fabarius, Alice, Pfirrmann, Markus, Schnittger, Susanne, Dengler, Jolanta, Falge, Christiane, Kanz, Lothar, Neubauer, Andreas, Stegelmann, Frank, Pfreundschuh, Michael, Waller, Cornelius F., Spiekermann, Karsten, Krause, Stefan W., Heim, Dominik, Nerl, Christoph, Hossfeld, Dieter K., Kolb, Hans-Jochem, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889634/
https://www.ncbi.nlm.nih.gov/pubmed/24162333
http://dx.doi.org/10.1007/s00277-013-1937-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889634/
https://www.ncbi.nlm.nih.gov/pubmed/24162333
http://dx.doi.org/10.1007/s00277-013-1937-4

Ejemplares similares